ID   TEBP_RAT                Reviewed;         160 AA.
AC   P83868;
DT   12-JUN-2007, integrated into UniProtKB/Swiss-Prot.
DT   12-JUN-2007, sequence version 2.
DT   02-OCT-2024, entry version 131.
DE   RecName: Full=Prostaglandin E synthase 3;
DE            EC=5.3.99.3 {ECO:0000269|PubMed:10922363};
DE   AltName: Full=Cytosolic prostaglandin E2 synthase;
DE            Short=cPGES;
DE   AltName: Full=Hsp90 co-chaperone;
DE   AltName: Full=Progesterone receptor complex p23;
DE   AltName: Full=Telomerase-binding protein p23;
GN   Name=Ptges3 {ECO:0000250|UniProtKB:Q15185};
GN   Synonyms=Tebp {ECO:0000250|UniProtKB:Q15185};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RG   The MGC Project Team;
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   PROTEIN SEQUENCE OF 1-20; 33-42 AND 53-62, CATALYTIC ACTIVITY, TISSUE
RP   SPECIFICITY, INDUCTION, AND PATHWAY.
RC   STRAIN=Wistar {ECO:0000269|PubMed:10922363};
RC   TISSUE=Brain {ECO:0000269|PubMed:10922363};
RX   PubMed=10922363; DOI=10.1074/jbc.m003504200;
RA   Tanioka T., Nakatani Y., Semmyo N., Murakami M., Kudo I.;
RT   "Molecular identification of cytosolic prostaglandin E2 synthase that is
RT   functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2
RT   biosynthesis.";
RL   J. Biol. Chem. 275:32775-32782(2000).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; SER-148 AND SER-151, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Cytosolic prostaglandin synthase that catalyzes the
CC       oxidoreduction of prostaglandin endoperoxide H2 (PGH2) to prostaglandin
CC       E2 (PGE2) (PubMed:10922363). Molecular chaperone that localizes to
CC       genomic response elements in a hormone-dependent manner and disrupts
CC       receptor-mediated transcriptional activation, by promoting disassembly
CC       of transcriptional regulatory complexes. Facilitates HIF alpha proteins
CC       hydroxylation via interaction with EGLN1/PHD2, leading to recruit
CC       EGLN1/PHD2 to the HSP90 pathway (By similarity).
CC       {ECO:0000250|UniProtKB:Q15185, ECO:0000269|PubMed:10922363}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=prostaglandin H2 = prostaglandin E2; Xref=Rhea:RHEA:12893,
CC         ChEBI:CHEBI:57405, ChEBI:CHEBI:606564; EC=5.3.99.3;
CC         Evidence={ECO:0000269|PubMed:10922363};
CC   -!- PATHWAY: Lipid metabolism; prostaglandin biosynthesis.
CC       {ECO:0000269|PubMed:10922363}.
CC   -!- SUBUNIT: Probably forms a complex composed of chaperones HSP90 and
CC       HSP70, co-chaperones STIP1/HOP, CDC37, PPP5C, PTGES3/p23, TSC1 and
CC       client protein TSC2. Binds to the progesterone receptor. Interacts with
CC       TERT; the interaction, together with HSP90AA1, is required for correct
CC       assembly and stabilization of the telomerase holoenzyme complex.
CC       Interacts (via PXLE motif) with EGLN1/PHD2, recruiting EGLN1/PHD2 to
CC       the HSP90 pathway to facilitate HIF alpha proteins hydroxylation.
CC       Interacts with HSP90AA1, FLCN, FNIP1 and FNIP2.
CC       {ECO:0000250|UniProtKB:Q15185}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q3ZBF7}.
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest levels in testis.
CC       {ECO:0000269|PubMed:10922363}.
CC   -!- INDUCTION: In brain, by LPS. {ECO:0000269|PubMed:10922363}.
CC   -!- PTM: Proteolytically cleaved by caspase-7 (CASP7) in response to
CC       apoptosis, leading to its inactivation. {ECO:0000250|UniProtKB:Q15185}.
CC   -!- SIMILARITY: Belongs to the p23/wos2 family. {ECO:0000255}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CK475788; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CK475788; -; NOT_ANNOTATED_CDS; mRNA.
DR   RefSeq; NP_001124461.1; NM_001130989.1.
DR   AlphaFoldDB; P83868; -.
DR   BMRB; P83868; -.
DR   SMR; P83868; -.
DR   BioGRID; 263737; 1.
DR   STRING; 10116.ENSRNOP00000003787; -.
DR   iPTMnet; P83868; -.
DR   PhosphoSitePlus; P83868; -.
DR   SwissPalm; P83868; -.
DR   jPOST; P83868; -.
DR   PaxDb; 10116-ENSRNOP00000003787; -.
DR   Ensembl; ENSRNOT00055023203; ENSRNOP00055018840; ENSRNOG00055013521.
DR   Ensembl; ENSRNOT00060041607; ENSRNOP00060034480; ENSRNOG00060023883.
DR   Ensembl; ENSRNOT00065021795; ENSRNOP00065016874; ENSRNOG00065013256.
DR   GeneID; 362809; -.
DR   KEGG; rno:362809; -.
DR   UCSC; RGD:1561913; rat.
DR   AGR; RGD:1561913; -.
DR   CTD; 10728; -.
DR   RGD; 1561913; Ptges3.
DR   VEuPathDB; HostDB:ENSRNOG00000002642; -.
DR   eggNOG; KOG3158; Eukaryota.
DR   HOGENOM; CLU_078883_1_2_1; -.
DR   InParanoid; P83868; -.
DR   OrthoDB; 782824at2759; -.
DR   PhylomeDB; P83868; -.
DR   TreeFam; TF315077; -.
DR   Reactome; R-RNO-2162123; Synthesis of Prostaglandins (PG) and Thromboxanes (TX).
DR   Reactome; R-RNO-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand.
DR   Reactome; R-RNO-3371511; HSF1 activation.
DR   Reactome; R-RNO-3371568; Attenuation phase.
DR   Reactome; R-RNO-8937144; Aryl hydrocarbon receptor signalling.
DR   Reactome; R-RNO-8939211; ESR-mediated signaling.
DR   Reactome; R-RNO-9018519; Estrogen-dependent gene expression.
DR   SABIO-RK; P83868; -.
DR   UniPathway; UPA00662; -.
DR   ChiTaRS; Ptges3; rat.
DR   PRO; PR:P83868; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000002642; Expressed in thymus and 19 other cell types or tissues.
DR   ExpressionAtlas; P83868; baseline and differential.
DR   GO; GO:0005884; C:actin filament; IDA:RGD.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0101031; C:protein folding chaperone complex; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0005697; C:telomerase holoenzyme complex; ISO:RGD.
DR   GO; GO:0070182; F:DNA polymerase binding; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; IPI:RGD.
DR   GO; GO:0051879; F:Hsp90 protein binding; IDA:RGD.
DR   GO; GO:0002039; F:p53 binding; IDA:RGD.
DR   GO; GO:0050220; F:prostaglandin-E synthase activity; IDA:RGD.
DR   GO; GO:0051087; F:protein-folding chaperone binding; IBA:GO_Central.
DR   GO; GO:0003720; F:telomerase activity; ISO:RGD.
DR   GO; GO:0051082; F:unfolded protein binding; ISS:UniProtKB.
DR   GO; GO:0051085; P:chaperone cofactor-dependent protein refolding; ISO:RGD.
DR   GO; GO:0051131; P:chaperone-mediated protein complex assembly; ISO:RGD.
DR   GO; GO:0048144; P:fibroblast proliferation; ISO:RGD.
DR   GO; GO:0005978; P:glycogen biosynthetic process; ISO:RGD.
DR   GO; GO:0060430; P:lung saccule development; ISO:RGD.
DR   GO; GO:0051402; P:neuron apoptotic process; IMP:RGD.
DR   GO; GO:0042921; P:nuclear receptor-mediated glucocorticoid signaling pathway; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:RGD.
DR   GO; GO:0042327; P:positive regulation of phosphorylation; ISO:RGD.
DR   GO; GO:0001516; P:prostaglandin biosynthetic process; IDA:RGD.
DR   GO; GO:0006693; P:prostaglandin metabolic process; IMP:RGD.
DR   GO; GO:0006457; P:protein folding; IBA:GO_Central.
DR   GO; GO:0050821; P:protein stabilization; ISO:RGD.
DR   GO; GO:0043588; P:skin development; ISO:RGD.
DR   GO; GO:1905323; P:telomerase holoenzyme complex assembly; ISO:RGD.
DR   GO; GO:0007004; P:telomere maintenance via telomerase; ISO:RGD.
DR   CDD; cd00237; p23; 1.
DR   Gene3D; 2.60.40.790; -; 1.
DR   InterPro; IPR007052; CS_dom.
DR   InterPro; IPR008978; HSP20-like_chaperone.
DR   InterPro; IPR045250; p23-like.
DR   PANTHER; PTHR22932:SF3; PROSTAGLANDIN E SYNTHASE 3; 1.
DR   PANTHER; PTHR22932; TELOMERASE-BINDING PROTEIN P23 HSP90 CO-CHAPERONE; 1.
DR   Pfam; PF04969; CS; 1.
DR   SUPFAM; SSF49764; HSP20-like chaperones; 1.
DR   PROSITE; PS51203; CS; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cytoplasm; Direct protein sequencing; Fatty acid biosynthesis;
KW   Fatty acid metabolism; Isomerase; Isopeptide bond; Lipid biosynthesis;
KW   Lipid metabolism; Phosphoprotein; Prostaglandin biosynthesis;
KW   Prostaglandin metabolism; Reference proteome; Ubl conjugation.
FT   CHAIN           1..160
FT                   /note="Prostaglandin E synthase 3"
FT                   /id="PRO_0000291382"
FT   DOMAIN          1..90
FT                   /note="CS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00547"
FT   REGION          118..160
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           157..160
FT                   /note="PXLE motif"
FT                   /evidence="ECO:0000250|UniProtKB:Q15185"
FT   COMPBIAS        119..136
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        137..160
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            142..143
FT                   /note="Cleavage; by caspase-7"
FT                   /evidence="ECO:0000250|UniProtKB:Q15185"
FT   MOD_RES         33
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15185"
FT   MOD_RES         44
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15185"
FT   MOD_RES         85
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15185"
FT   MOD_RES         100
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R0Q7"
FT   MOD_RES         113
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         118
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15185"
FT   MOD_RES         148
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         151
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CROSSLNK        35
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q15185"
FT   CROSSLNK        65
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q15185"
FT   CONFLICT        2
FT                   /note="Q -> D (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        37
FT                   /note="T -> C (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   160 AA;  18721 MW;  7702CB59D7AFD739 CRC64;
     MQPASAKWYD RRDYVFIEFC VEDSKDVNVN FEKSKLTFSC LGGSDNFKHL NEIDLFHCID
     PNDSKHKRTD RSILCCLRKG ESGQSWPRLT KERAKLNWLS VDFNNWKDWE DDSDEDMSNF
     DRFSEMMDHM GGDEDVDLPE VDGADDDSQD SDDEKMPDLE
//
